NEW YORK (GenomeWeb News) ─ Myriad Genetics has submitted to the US Food and Drug Administration the first module of its premarket approval application for BRACAnalysis as a companion test for AstraZeneca's breast cancer PARP inhibitor olaparib.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
The House of Lords in the UK approves a bill to allow mitochondrial donation.